Unique Questions Associated With the Increasing Prominence of Precision/Genomic Medicine in Routine Cancer Care
Maurie Markman, MD, delves into questions regarding precision medicine and genetic testing in cancer.
Maurie Markman, MD, delves into questions regarding precision medicine and genetic testing in cancer.
Peripheral blood absolute lymphocyte count at diagnosis is an effective biomarker that can be used to risk-stratify patients with multiple myeloma, according to retrospective study…
Survey-based research in radiation oncology (RO) is widely used as a valuable tool to evaluate the implementation of novel radiotherapy technologies [1–5], examine practice patterns…
Yash Chhabra, PhD, Assistant Professor in the Cancer Signaling and Microenvironment Research Program, was recently honored with the American Association for Cancer Research’s NextGen Stars…
$700,000 over three years for female associate professors performing research that has a direct applicability and relevance to the understanding, prevention, interception, early detection, diagnosis,…
FDA is revoking the authorization for the use of FD&C Red No. 3 as a matter of law, based on the Delaney Clause of the…
Key PointsAPC is a pleiotropic protease with diverse functions derived from its anticoagulant, anti-inflammatory, and cytoprotective activities.Single amin
In an interview, Andrew Kuykendall, MD, discussed fedratinib’s potential as an effective option for patients with myelodysplastic syndrome/myeloproliferative neoplasms and chronic neutrophilic leukemia.
Our paid undergraduate summer scholarships offer undergraduate students a chance to gain hands-on cancer research experience.
Moazzam Shahzad H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Moazzam Shahzad , Ahmad Basharat , Sohaib Irfan , Jawad Noor…
In 1999, Richard Pazdur, a GI oncologist at MD Anderson, saw an FDA recruitment ad in The New England Journal of Medicine. The agency was…